Principal Financial Group Inc. Trims Holdings in Ralliant Corporation $RAL

Principal Financial Group Inc. reduced its holdings in shares of Ralliant Corporation (NYSE:RAL) by 20.5% during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 540,932 shares of the company’s stock after selling 139,242 shares during the period. Principal Financial Group Inc. owned approximately 0.48% of Ralliant worth $23,655,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently bought and sold shares of RAL. Manchester Capital Management LLC acquired a new stake in shares of Ralliant during the second quarter worth about $29,000. Westfuller Advisors LLC purchased a new stake in Ralliant during the 3rd quarter valued at approximately $26,000. UMB Bank n.a. acquired a new stake in Ralliant during the 3rd quarter worth approximately $29,000. Evermay Wealth Management LLC purchased a new position in shares of Ralliant in the 2nd quarter valued at approximately $32,000. Finally, Webster Bank N. A. acquired a new position in shares of Ralliant in the third quarter valued at approximately $31,000.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on RAL shares. Oppenheimer decreased their price target on Ralliant from $60.00 to $50.00 and set an “outperform” rating for the company in a report on Friday. Vertical Research raised shares of Ralliant from a “hold” rating to a “buy” rating and set a $45.00 target price on the stock in a report on Friday. Truist Financial dropped their price target on shares of Ralliant from $62.00 to $49.00 and set a “buy” rating on the stock in a research note on Friday. Citigroup reduced their price objective on shares of Ralliant from $61.00 to $51.00 and set a “buy” rating for the company in a research report on Friday. Finally, Morgan Stanley reaffirmed an “overweight” rating and issued a $45.00 price objective on shares of Ralliant in a report on Friday. Seven research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Ralliant currently has an average rating of “Moderate Buy” and a consensus target price of $51.30.

Key Headlines Impacting Ralliant

Here are the key news stories impacting Ralliant this week:

• Positive Sentiment: Analyst upgrades: Vertical Research upgraded Ralliant from “hold” to “buy” with a $45 price target, which supports near‑term upside expectations. The Fly: Vertical Research upgrade
• Positive Sentiment: Citigroup maintained a “buy” rating (but trimmed its PT to $51 from $61), which still implies meaningful upside and likely helped calm some selling pressure. Benzinga: Citigroup note
• Positive Sentiment: Quarterly results modestly beat: Q4 EPS of $0.69 (vs. $0.67 est.) and revenue of ~$554.6M (vs. $543M est.), showing underlying operational resilience despite the one‑time items. MarketBeat: Q4 results
• Neutral Sentiment: Company set 2026 revenue target of $2.1B–$2.2B (roughly in line with consensus), which supports the topline outlook but is tempered by other items below. BusinessWire: FY2026 outlook
• Negative Sentiment: Material non‑cash charge: the company recorded a $1.4B goodwill impairment in its Test & Measurement segment (EA Elektro‑Automatik), producing a large reported net loss and triggering the recent sharp selloff. MarketWatch: $1.4B impairment
• Negative Sentiment: Multiple law‑firm investigations and investor notices (Holzer & Holzer, Johnson Fistel, Block & Leviton) are underway into the impairment and disclosures, adding legal/exec‑risk uncertainty. GlobeNewswire: Investor alerts
• Negative Sentiment: Shares recently hit an all‑time low after the impairment and heavy losses were disclosed, which can pressure sentiment until clarity on write‑ups, integration and legal outcomes emerges. InsiderMonkey: All‑time low coverage

Ralliant Stock Up 2.9%

Shares of NYSE RAL opened at $39.50 on Friday. The stock has a market capitalization of $4.46 billion and a price-to-earnings ratio of 31.10. Ralliant Corporation has a 52 week low of $37.27 and a 52 week high of $57.02. The firm has a 50-day moving average price of $51.52 and a 200 day moving average price of $46.72. The company has a quick ratio of 1.03, a current ratio of 0.84 and a debt-to-equity ratio of 0.38.

Ralliant (NYSE:RAL) last issued its earnings results on Wednesday, February 4th. The company reported $0.69 earnings per share for the quarter, topping the consensus estimate of $0.67 by $0.02. The company had revenue of $554.60 million for the quarter, compared to analyst estimates of $543.04 million. The business’s quarterly revenue was up 1.2% compared to the same quarter last year. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 23rd. Investors of record on Monday, March 9th will be issued a dividend of $0.05 per share. The ex-dividend date of this dividend is Monday, March 9th. This represents a $0.20 annualized dividend and a yield of 0.5%. Ralliant’s payout ratio is currently 15.75%.

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.